BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 13, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

CH-4051: Phase II start

Next month, Chelsea will begin a double-blind, international Phase II trial in 250 patients to evaluate once-daily 0.3, 1 or 3 mg of oral CH-4051 alone, once-daily...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >